<DOC>
	<DOC>NCT03094403</DOC>
	<brief_summary>A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study</brief_summary>
	<brief_title>To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel</brief_title>
	<detailed_description>A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, comparing AZELAIC ACID TOPICAL GEL 15% TO FINACEA® and both active treatments to a Placebo Control in the treatment of Moderate of Facial Rosacea.</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Healthy male or nonpregnant female ≥ 18 yearsofage with a clinical diagnosis of moderate facial rosacea; Subjects had to have a definite clinical diagnosis of facial rosacea severity Grade 3 as per the IGE Female subjects who were pregnant, nursing, or planning to become pregnant during study participation;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>